← Leaderboards
Moran Amit
University Of Tx Md Anderson Can Ctr
$4,840,424
Attributed
$6,265,509
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,265,509 · 4
By mechanism
R37$3,415,339 · 1
R01$2,825,170 · 1
R13$25,000 · 2
Top collaborators
- George A. Calin5 shared
- Nisha J D'Silva1 shared
- Monty A Montano1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- George A. Calin$5,774,539
- Anil K Sood$29,572,737
- Min Gyu Lee$8,063,863
- Ronald Anthony Depinho$97,148,322
- Abdullah Ali Osman$1,994,753
Others in their field
Other Emerging Leaders on “Oncology”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$65,477,924
- Martha Hering · Westat, Inc.$57,098,843
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- Jennifer Marie Suga · Kaiser Foundation Research Institute$32,396,809
- Gregg Kravatz$29,338,050
Research focus
OncologyNeuroepithelial, Perineurial, And Schwann Cell NeoplasmPlayCancer BiologyMalignant NeoplasmsNeurobiologyPeripheral Nervous SystemTumor MicroenvironmentProgramsTumorCancer TherapyCancer CellQuality Of LifeNerveGrowthTumor ProgressionNerve FibersCellsNeuronsInnovationCellular BiologyEventAdrenergic AgentsGenetic Approach
Grant awards (16)
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance$910,254
R37 · FY2025 · CA · contact PI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$678,424
R01 · FY2025 · DE · contact PI
Cancer Neuroscience: Crossing Disciplines to Revolutionize Cancer Treatment$10,000
R13 · FY2025 · CA · contact PI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$664,854
R01 · FY2024 · DE · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$434,780
R37 · FY2024 · CA · contact PI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$130,434
R01 · FY2024 · DE · contact PI
Cancer Neuroscience - An Emerging Hallmark$15,000
R13 · FY2024 · CA · contact PI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$678,424
R01 · FY2023 · DE · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$448,510
R37 · FY2023 · CA · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$67,758
R37 · FY2023 · CA · contact PI
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer$673,034
R01 · FY2022 · DE · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$457,663
R37 · FY2022 · CA · contact PI
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance$69,142
R37 · FY2022 · CA · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$457,663
R37 · FY2021 · CA · contact PI
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance$111,906
R37 · FY2021 · CA · contact PI
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance$457,663
R37 · FY2020 · CA · contact PI